Gene · 9475
Papers3,801
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 3,801
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Liver-specific LINC01146, a promising prognostic indicator, inhibits the malignant phenotype of hepatocellular carcinoma cells both in vitro and in vivo. | J Transl Med | 2022 | 35101062 | PubTator, text mining | PubMed |
| Small nucleolar RNA SNORA71A promotes epithelial-mesenchymal transition by maintaining ROCK2 mRNA stability in breast cancer. | Mol Oncol | 2022 | 35100495 | PubTator, text mining | PubMed |
Apolipoprotein (a)/Lipoprotein(a)-Induced Oxidative-Inflammatory α7-nAChR/p38 MAPK/IL-6/RhoA-GTP Signaling Axis and M1 Macrophage Polarization Modulate Inflammation-Associated Development of Coronary Artery Spasm. | Oxid Med Cell Longev | 2022 | 35096275 | PubTator, text mining | PubMed |
| CTNNAL1 participates in the regulation of mucus overproduction in HDM-induced asthma mouse model through the YAP-ROCK2 pathway. | J Cell Mol Med | 2022 | 35092120 | PubTator, text mining | PubMed |
| Crosslinking-Induced Corneal Endothelium Dysfunction and Its Protection by Topical Ripasudil Treatment. | Dis Markers | 2022 | 35069933 | PubTator, text mining | PubMed |
| Estrogen receptor beta promotes lung cancer invasion via increasing CXCR4 expression. | Cell Death Dis | 2022 | 35064116 | PubTator, text mining | PubMed |
| RNA-binding proteins in ovarian cancer: a novel avenue of their roles in diagnosis and treatment. | J Transl Med | 2022 | 35062979 | PubTator, text mining | PubMed |
| Transcriptional Analysis-Based Alterations Affecting Neuritogenesis of the Peripheral Nervous System in Psoriasis. | Life (Basel) | 2022 | 35054504 | PubTator, text mining | PubMed |
| The Role of miRNA in Regulating the Fate of Monocytes in Health and Cancer. | Biomolecules | 2022 | 35053248 | PubTator, text mining | PubMed |
| Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches. | Biomedicines | 2022 | 35052842 | PubTator, text mining | PubMed |
| Effects of tRNA-derived fragments and microRNAs regulatory network on pancreatic acinar intracellular trypsinogen activation. | Bioengineered | 2022 | 35045793 | PubTator, text mining | PubMed |
| Rho Kinases in Embryonic Development and Stem Cell Research. | Arch Immunol Ther Exp (Warsz) | 2022 | 35043239 | PubTator, text mining | PubMed |
| The gut microbiota can be a potential regulator and treatment target of bone metastasis. | Biochem Pharmacol | 2022 | 35041811 | PubTator, text mining | PubMed |
| Circular RNA CUL2 regulates the development of colorectal cancer by modulating apoptosis and autophagy via miR-208a-3p/PPP6C. | Aging (Albany NY) | 2022 | 35027503 | PubTator, text mining | PubMed |
| Clinical significance of metabolism-related genes and FAK activity in ovarian high-grade serous carcinoma. | BMC Cancer | 2022 | 35027024 | PubTator, text mining | PubMed |
| Matrix Mechanotransduction via Yes-Associated Protein in Human Lamina Cribrosa Cells in Glaucoma. | Invest Ophthalmol Vis Sci | 2022 | 35015027 | PubTator, text mining | PubMed |
| A Protein Composite Neural Scaffold Modulates Astrocyte Migration and Transcriptome Profile. | Macromol Biosci | 2022 | 35014754 | PubTator, text mining | PubMed |
| MicroRNA-381 in human cancer: Its involvement in tumour biology and clinical applications potential. | J Cell Mol Med | 2022 | 35014178 | PubTator, text mining | PubMed |
| Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis. | J Med Chem | 2022 | 34985276 | PubTator, text mining | PubMed |
| Circ_0078607 inhibits the progression of ovarian cancer via regulating the miR-32-5p/SIK1 network. | J Ovarian Res | 2022 | 34983607 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9475/papers?page=52